Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 2
2017 5
2018 6
2019 8
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Dysregulation of the gut-brain axis in schizophrenia and bipolar disorder: probiotic supplementation as a supportive treatment in psychiatric disorders.
Genedi M, Janmaat IE, Haarman BBCM, Sommer IEC. Genedi M, et al. Curr Opin Psychiatry. 2019 May;32(3):185-195. doi: 10.1097/YCO.0000000000000499. Curr Opin Psychiatry. 2019. PMID: 30920970 Review.
The authors in this review provide an overview of this emerging research field and summarize both the publicated microbiome studies in SCZ and bipolar disorder and the current clinical research using probiotic supplementation in patients diagnosed with these …
The authors in this review provide an overview of this emerging research field and summarize both the publicated microbiome studies in SCZ a …
The microbiome, immunity, and schizophrenia and bipolar disorder.
Dickerson F, Severance E, Yolken R. Dickerson F, et al. Brain Behav Immun. 2017 May;62:46-52. doi: 10.1016/j.bbi.2016.12.010. Epub 2016 Dec 18. Brain Behav Immun. 2017. PMID: 28003152 Free PMC article. Review.
Schizophrenia and bipolar disorder are serious neuropsychiatric disorders of uncertain etiology. Recent studies indicate that immune activation may contribute to the etiopathogenesis of these disorders. ...Other studies have found increased gastrointestinal inflamma …
Schizophrenia and bipolar disorder are serious neuropsychiatric disorders of uncertain etiology. Recent studies indicate that …
Gut microbiota in autism and mood disorders.
Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A. Mangiola F, et al. World J Gastroenterol. 2016 Jan 7;22(1):361-8. doi: 10.3748/wjg.v22.i1.361. World J Gastroenterol. 2016. PMID: 26755882 Free PMC article. Review.
In the last few years, the importance of gut microbiota impairment in the etiopathogenesis of pathology such as autism, dementia and mood disorder, has been raised. The evidence of the inflammatory state alteration, highlighted in disorders such as schizophrenia, major dep …
In the last few years, the importance of gut microbiota impairment in the etiopathogenesis of pathology such as autism, dementia and mood …
Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.
Gondalia S, Parkinson L, Stough C, Scholey A. Gondalia S, et al. Psychopharmacology (Berl). 2019 May;236(5):1433-1443. doi: 10.1007/s00213-019-05248-6. Epub 2019 Apr 30. Psychopharmacology (Berl). 2019. PMID: 31041459 Review.
Non-pharmaceutical targets for management of mood disorders, such as bipolar disorder, are relatively under-researched. At the same time, it is clear that there is an intimate connection between psychiatry and gastrointestinal health. ...Further in this review, we e …
Non-pharmaceutical targets for management of mood disorders, such as bipolar disorder, are relatively under-researched. At the …
Nutritional psychiatry: the present state of the evidence.
Marx W, Moseley G, Berk M, Jacka F. Marx W, et al. Proc Nutr Soc. 2017 Nov;76(4):427-436. doi: 10.1017/S0029665117002026. Epub 2017 Sep 25. Proc Nutr Soc. 2017. PMID: 28942748 Review.
Mental illness, including depression, anxiety and bipolar disorder, accounts for a significant proportion of global disability and poses a substantial social, economic and heath burden. ...Furthermore, nutraceuticals including n-3 fatty acids, folate, S-adeno …
Mental illness, including depression, anxiety and bipolar disorder, accounts for a significant proportion of global disability …
Targeting the immune system in the treatment of bipolar disorder.
Rosenblat JD. Rosenblat JD. Psychopharmacology (Berl). 2019 Oct;236(10):2909-2921. doi: 10.1007/s00213-019-5175-x. Epub 2019 Feb 13. Psychopharmacology (Berl). 2019. PMID: 30756134 Review.
RATIONALE: Immune dysfunction has been strongly implicated in the pathophysiology of bipolar disorder (BD). As such, numerous clinical trials have investigated the effects of anti-inflammatory agents in the treatment of BD. ...CONCLUSIONS: Several proof-of-concept c …
RATIONALE: Immune dysfunction has been strongly implicated in the pathophysiology of bipolar disorder (BD). As such, numerous …
Probiotic Treatment in Individuals with Euthymic Bipolar Disorder: A Pilot-Study on Clinical Changes and Compliance.
Reininghaus EZ, Wetzlmair LC, Fellendorf FT, Platzer M, Queissner R, Birner A, Pilz R, Hamm C, Maget A, Rieger A, Prettenhofer A, Wurm W, Mörkl S, Dalkner N. Reininghaus EZ, et al. Neuropsychobiology. 2020;79(1):71-79. doi: 10.1159/000493867. Epub 2018 Oct 19. Neuropsychobiology. 2020. PMID: 30343291
The current report of the ProbioBIP-one pilot study aims at describing general effects of the intake of the probiotic OMNi-BiOTiC Stress repair® on psychological parameters as well as gastrointestinal symptoms and general compliance in a cohort of euthymic individuals with …
The current report of the ProbioBIP-one pilot study aims at describing general effects of the intake of the probiotic OMNi-BiOTiC Str …
The Impact of Probiotic Supplements on Cognitive Parameters in Euthymic Individuals with Bipolar Disorder: A Pilot Study.
Reininghaus EZ, Wetzlmair LC, Fellendorf FT, Platzer M, Queissner R, Birner A, Pilz R, Hamm C, Maget A, Koidl C, Riedrich K, Klampfer K, Ferk K, Dalkner N. Reininghaus EZ, et al. Neuropsychobiology. 2018 Sep 18:1-8. doi: 10.1159/000492537. Online ahead of print. Neuropsychobiology. 2018. PMID: 30227422
INTRODUCTION: Cognitive dysfunction is prevalent in depressive as well as manic episodes in individuals with Bipolar Disorder (BD). ...Nevertheless, the idea of this potential new treatment is challenging because of the variety of the human's gut microbiota.. …
INTRODUCTION: Cognitive dysfunction is prevalent in depressive as well as manic episodes in individuals with Bipolar Disorder
The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials.
Fusar-Poli L, Surace T, Vanella A, Meo V, Patania F, Furnari R, Signorelli MS, Aguglia E. Fusar-Poli L, et al. J Affect Disord. 2019 Jun 1;252:334-349. doi: 10.1016/j.jad.2019.04.039. Epub 2019 Apr 8. J Affect Disord. 2019. PMID: 30999090
We included only original randomized controlled trials written in English, testing the efficacy of nutraceuticals in add-on to standard care, compared to placebo, in patients with bipolar disorder. ...CONCLUSIONS: Evidence regarding the efficacy of adjunctive nutrac …
We included only original randomized controlled trials written in English, testing the efficacy of nutraceuticals in add-on to standard care …
Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics.
Vazquez GH, Camino S, Tondo L, Baldessarini RJ. Vazquez GH, et al. CNS Neurol Disord Drug Targets. 2017;16(8):858-869. doi: 10.2174/1871527316666170728165648. CNS Neurol Disord Drug Targets. 2017. PMID: 28758582
BACKGROUND: Treatments for depression in bipolar disorder (BD) are far less well developed than for unipolar major depressive disorder. ...The concept of altering intestinal flora with probiotic treatments to treat mood disorders remains speculative. C …
BACKGROUND: Treatments for depression in bipolar disorder (BD) are far less well developed than for unipolar major depressive …
23 results
Jump to page
Feedback